May 4, 2023LIfT BioSciences announces data demonstrating potent killing of pancreatic cancer tumouroidsIMAN demonstrated potent direct killing of a patient derived pancreatic ductal adenocarcinoma tumouroid model IMAN is the world’s first...
Mar 21, 2023LIfT BioSciences announces breakthrough preclinical data demonstrating dual mode of action LIfT BioSciences announces breakthrough preclinical data demonstrating the dual mode of action commonly believed necessary for curing solid
Feb 16, 2023LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing PartnershipGMP N-LIfT being produced for forthcoming clinical trials LONDON, UK and MUNICH, Germany – February 16th, 2023. LIfT BioSciences, a...